The Annals Evolution of Clinical Pharmacy | Now Available
home help contact us subscription past issues search current issue
 QUICK SEARCH:   [advanced]


     


Drug Intelligence & Clinical Pharmacy: Vol. 21, No. 4, pp. 346-351.
© 1987 Harvey Whitney Books Company.
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aronson, I.
Right arrow Articles by Paloucek, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aronson, I.
Right arrow Articles by Paloucek, F.


Research Articles

Evaluation of topical metronidazole gel in acne rosacea

IK Aronson, JA Rumsfield, DP West, J Alexander, JH Fischer, and FP Paloucek

Topical metronidazole gel (0.75%) was compared to placebo gel in a randomized, double-blind, placebo-controlled, split-face clinical trial for the treatment of 59 patients with acne rosacea. Statistically significant differences in inflammatory lesions, erythema, and global assessments were seen at three, six, and nine weeks post-baseline in favor of the active treatment side. It did not, however, alter the telangiectatic component of the disease. No known drug-related side effects were detected, and the low topical dose along with low serum levels of metronidazole indicate a high safety profile for this therapeutic agent. This work suggests that metronidazole gel, as specifically formulated, is safe and effective in reducing the symptomatology of acne rosacea.


This article has been cited by other articles:


Home page
Journal of the American Dental AssociationHome page
S. S. FUCHS
Identifying rosacea: What all dentists should know
J Am Dent Assoc, May 1, 2003; 134(5): 603 - 607.
[Abstract] [Full Text] [PDF]


Home page
Arch DermatolHome page
M. V. Dahl, H. I. Katz, G. G. Krueger, L. E. Millikan, R. B. Odom, F. Parker, J. E. Wolf Jr, R. Aly, C. Bayles, B. Reusser, et al.
Topical Metronidazole Maintains Remissions of Rosacea
Arch Dermatol, June 1, 1998; 134(6): 679 - 683.
[Abstract] [Full Text] [PDF]




homecopy help contact us subscription past issues search current issue
Copyright © 1987 by Harvey Whitney Books Company.